Coldstream Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,436
Closed -$213K 1244
2025
Q3
$213K Buy
+11,436
New +$214K ﹤0.01% 1118
2025
Q2
Sell
-9,594
Closed -$168K 2926
2025
Q1
$168K Buy
+9,594
New +$162K ﹤0.01% 1085
2022
Q2
$155K Buy
11,139
+284
+3% +$3.8K 0.01% 745
2022
Q1
$162K Sell
10,855
-1,900
-15% -$26K 0.01% 759
2021
Q4
$173K Buy
+12,755
New +$180K 0.01% 825

Other funds holding SBRA

Coldstream Capital Management's SBRA Position: Q4 2025 in Review

Coldstream Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 11,436 shares — an estimated $213K sold.

Coldstream Capital Management first reported a position in SBRA in Q4 2021 and held it in 5 quarters. The position peaked at $213K in Q3 2025. 440 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Coldstream Capital Management reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 11,436 Sabra Healthcare REIT shares in Q4 2025, an estimated $213K.
  • Coldstream Capital Management first reported a position in Sabra Healthcare REIT in Q4 2021 and held it in 5 quarters.
  • Coldstream Capital Management's Sabra Healthcare REIT position peaked at $213K in Q3 2025.
  • 440 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Coldstream Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.